CD19-CAR-T Cells Are Effective and Safe Treatment of Post-Transplant Relapse in Pediatric and Young Adult Patients with B-Lineage ALL: Real-World Data from Germany

Bader P, Rossig C, Hutter M, Ayuk FA, Baldus CD, Buecklein VL, Bonig H, Cario G, Einsele H, Holtick U, Koenecke C, Kuenkele A, Meisel R, Müller F, Mueller I, Penack O, Rettinger E, Sauer MG, Schlegel PG, Soerensen J, Von Stackelberg A, Feuchtinger T, Jarisch A (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Blood American Society of Hematology

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Pages Range: 10407-10409

Conference Proceedings Title: BLOOD

DOI: 10.1182/blood-2022-156775

Authors with CRIS profile

Fabian Müller Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Goethe-Universität Frankfurt am Main

Germany (DE) Universitätsklinikum Münster

Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE)

Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH)

Germany (DE) Ludwig-Maximilians-Universität (LMU)

Germany (DE) Universitätsklinikum Würzburg

Germany (DE) Universitätsklinikum Köln

Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School

Germany (DE) Charité - Universitätsmedizin Berlin

Germany (DE) Heinrich-Heine-Universität Düsseldorf

Germany (DE)

How to cite

APA:

Bader, P., Rossig, C., Hutter, M., Ayuk, F.A., Baldus, C.D., Buecklein, V.L.,... Jarisch, A. (2022). CD19-CAR-T Cells Are Effective and Safe Treatment of Post-Transplant Relapse in Pediatric and Young Adult Patients with B-Lineage ALL: Real-World Data from Germany. In BLOOD (pp. 10407-10409). WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Bader, Peter, et al. "CD19-CAR-T Cells Are Effective and Safe Treatment of Post-Transplant Relapse in Pediatric and Young Adult Patients with B-Lineage ALL: Real-World Data from Germany." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2022. 10407-10409.

BibTeX: Download